Dr. Ranji Bindra explains the delicate balance that must go into treating the parents of patients in pediatric oncology.
Ranjit Bindra, MD, PhD, from Smilow Cancer Hospital at Yale explains the importance of communicating honestly and sensitively with parents when treating pediatric patients.
In pediatric oncology, nurses have to treat both the patient and the family. This requires a delicate balance that allows the parents to be hopeful and engaged, but realistic. Bindra highlights the importance of revising communication in relation to the patient's status.
FDA Approves Inotuzumab Ozogamicin for Pediatric Patients With ALL
March 6th 2024The antibody-drug conjugate inotuzumab ozogamicin was approved by the FDA for the treatment of patients aged 1 year and older with relapsed or refractory CD22-positive B-cell precursor acute lymphoblastic leukemia.
FDA Approves Inotuzumab Ozogamicin for Pediatric Patients With ALL
March 6th 2024The antibody-drug conjugate inotuzumab ozogamicin was approved by the FDA for the treatment of patients aged 1 year and older with relapsed or refractory CD22-positive B-cell precursor acute lymphoblastic leukemia.
Olaparib Plus Chemo May Not Improve Outcomes vs Chemo Alone in BRCA Wild-Type TNBC
Less Than Half of Recently Approved Cancer Drugs Show a Clinical Benefit
Cadonilimab Plus Chemo Provides Survival Benefit in Gastric/GEJ Cancer
Lenvatinib Plus Pembrolizumab Improves Survival in Advanced/Recurrent Endometrial Cancer
2 Commerce Drive
Cranbury, NJ 08512